219 related articles for article (PubMed ID: 29198824)
1. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
Ma Y; Cheng Z; Liu J; Torre-Healy L; Lathia JD; Nakano I; Guo Y; Thompson RC; Freeman ML; Wang J
Stem Cell Reports; 2017 Dec; 9(6):1948-1960. PubMed ID: 29198824
[TBL] [Abstract][Full Text] [Related]
2. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
[TBL] [Abstract][Full Text] [Related]
3. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
4. Notch promotes radioresistance of glioma stem cells.
Wang J; Wakeman TP; Lathia JD; Hjelmeland AB; Wang XF; White RR; Rich JN; Sullenger BA
Stem Cells; 2010 Jan; 28(1):17-28. PubMed ID: 19921751
[TBL] [Abstract][Full Text] [Related]
5. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
[TBL] [Abstract][Full Text] [Related]
6. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy.
Ghanbari-Movahed M; Ghanbari-Movahed Z; Momtaz S; Kilpatrick KL; Farzaei MH; Bishayee A
Molecules; 2021 Feb; 26(4):. PubMed ID: 33673088
[TBL] [Abstract][Full Text] [Related]
7. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
BeLow M; Osipo C
Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
[TBL] [Abstract][Full Text] [Related]
9. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
Yun HS; Lee J; Kil WJ; Kramp TR; Tofilon PJ; Camphausen K
Mol Cancer Ther; 2021 Sep; 20(9):1672-1679. PubMed ID: 34158343
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
Gersey Z; Osiason AD; Bloom L; Shah S; Thompson JW; Bregy A; Agarwal N; Komotar RJ
World Neurosurg; 2019 Nov; 131():252-263.e2. PubMed ID: 31376551
[TBL] [Abstract][Full Text] [Related]
11. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
12. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
13. z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response.
Monticone M; Biollo E; Fabiano A; Fabbi M; Daga A; Romeo F; Maffei M; Melotti A; Giaretti W; Corte G; Castagnola P
Mol Cancer Res; 2009 Nov; 7(11):1822-34. PubMed ID: 19861404
[TBL] [Abstract][Full Text] [Related]
14. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
15. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade.
Chu Q; Orr BA; Semenkow S; Bar EE; Eberhart CG
Clin Cancer Res; 2013 Jun; 19(12):3224-33. PubMed ID: 23630166
[TBL] [Abstract][Full Text] [Related]
16. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
17. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
Jung Y; Park H; Zhao HY; Jeon R; Ryu JH; Kim WY
Mol Cells; 2014 Jul; 37(7):547-53. PubMed ID: 25078449
[TBL] [Abstract][Full Text] [Related]
18. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
[TBL] [Abstract][Full Text] [Related]
19. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
[TBL] [Abstract][Full Text] [Related]
20. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]